Diagnostic and clinical impact of disseminated tumour cells in bone marrow;Diagnostik und klinische bedeutung von disseminierten tumorzellen im knochenmark

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 41, 2000, Pages 1237-1239

  Braun, S ^a   Pantel, K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; TUMOR ANTIGEN;

BONE MARROW CANCER; BREAST CARCINOMA; CANCER CELL; CANCER MORTALITY; HUMAN; IMMUNOCYTOCHEMISTRY; METASTASIS; PROGNOSIS; REVIEW;

BONE MARROW; BONE MARROW EXAMINATION; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; CERVIX NEOPLASMS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KERATIN; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM CIRCULATING CELLS; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0034644581     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7730     Document Type: Review

References (13)

1. Standardisation of the immunocytochemical detection of cancer cells in bone marrow and blood: 1. Establishment of objective criteria for the evaluation of immunostained cells
2. Monoclonal antibody therapy with edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow
3. Tumor antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
4. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
5. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
6. Immunzytochemischer Tumorzellnachweis im Knochenmark - Indikationen und klinische Relevanz
7. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer
8. Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells
9. Classification of isolated tumor cells and micrometastases
10. Detection and clinical importance of micrometastic disease
11. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
12. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
13. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-171A monoclonal antibodies